A Single-Central, Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial Protocol: A Clinical Effect Evaluation Study on the TCM Comprehensive Intervention Program for Chronic Heart Failure
Table1
Schedule of intervention and assessments.
Study Period
Enrolment
Allocation
After allocation
Intervention phase 1
Washout
Intervention phase 2
Follow-up
Time point
Wk 1
Wk 0
Wk 1
Wk 2
Wk 3
Wk 4
Wk 5
Wk 6
Wk 7
Wk 8
Wk 9
Wk 10
6 mo
12 mo
Enrolment
Eligibility screen
×
Informed consent
×
Randomization
×
Interventions
Group A
Group B
AssessmentsPrimary outcome
NYHA classification
×
×
×
×
Secondary outcomes
Echocardiogram
×
×
×
×
NT-proBNP
×
×
×
×
CHFQLS
×
×
×
×
TCM syndrome score
×
×
×
×
Symptom score
×
×
×
×
Sign score
×
×
×
×
6MWT
×
×
×
×
PSQI
×
×
×
×
MoCA
×
×
×
×
MACEs
×
×
×
×
×
×
Metabolomics
×
×
Safety outcomes
Liver and kidney function
×
×
×
×
ARs
×
×
×
Schedule of enrollment, intervention, and assessment for the MIRACLE trial was according to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) [21]. Wk, week; mo, month.